Insider Trading - Lyons-Williams Lori
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-01-09 Option Award | 2017-01-10 4:19 pm | N/A 2027-01-08 | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2018-02-15 Option Award | 2018-02-16 5:40 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 10,630 | $0 | 75,259 (Direct) | View |
| 2018-02-15 Option Award | 2018-02-16 5:40 pm | N/A 2028-02-15 | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 63,750 | $28.25 | 75,259 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 4:05 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 60,000 | $0 | 72,183 (Direct) | View |
| 2018-08-15 Exercise | 2018-08-17 4:05 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 1,063 | $0 | 72,183 (Direct) | View |
| 2018-08-15 Tax Withholding | 2018-08-17 4:05 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 368 | $9.58 | 72,183 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 7:58 pm | N/A 2029-02-11 | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 80,000 | $0 | 82,617 (Direct) | View |
| 2019-05-17 Tax Withholding | 2019-05-21 4:03 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 10,374 | $10.5 | 53,794 (Direct) | View |
| 2019-05-17 Exercise | 2019-05-21 4:03 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 30,000 | $0 | 53,794 (Direct) | View |
| 2019-06-23 Option Award | 2019-06-25 4:10 pm | N/A 2029-06-22 | FIVE PRIME THERAPEUTICS INC | FPRX | Lyons-Williams Lori Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-08-15 Exercise | 2019-08-19 9:49 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 3,189 | $0 | 31,779 (Direct) | View |
| 2019-08-15 Tax Withholding | 2019-08-19 9:49 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 1,582 | $7.91 | 31,779 (Direct) | View |
| 2020-02-20 Disposition | 2020-02-24 7:32 pm | N/A 2027-01-08 | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 280,128 | $0 | 0 (Direct) | View |
| 2020-02-20 Disposition | 2020-02-24 7:32 pm | N/A N/A | Dermira Inc. | DERM | Lyons-Williams Lori Chief Commercial Officer | 25,401 | $18.75 | 0 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-15 5:30 pm | N/A 2030-05-13 | FIVE PRIME THERAPEUTICS Inc | FPRX | Lyons-Williams Lori Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS Inc | FPRX | Lyons-Williams Lori Director | 45,000 | $0 | 0 (Direct) | View |
| 2021-11-09 Option Award | 2021-11-10 8:22 pm | N/A 2031-11-09 | RAPT Therapeutics Inc. | RAPT | Lyons-Williams Lori Director | 22,500 | $0 | 22,500 (Direct) | View |